AI assistant
Morepen Laboratories Ltd. Capital/Financing Update 2019
59389_rns_2019-09-19_2ad0b3bf-c022-453e-b3f0-856f88c705f8.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Date: 19/09/2019
To,
National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051 Tel No: (022) 26598100- 8114 Phones: 91-22-22721233/4 Fax No: (022) 26598120 Fax: 91-22-2272 3121 Symbol: MOREPENLAB Scrip Code: 500288
BSE Limited
Floor 25, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001
Subject: Outcome of the Board Meeting held on 19th September, 2019
Ref.: Intimation under Regulation 30 and other applicable Regulations of SEBI (Listing Obligations & Disclosure Requirements), Regulations 2015, as amended.
Dear Sir,
This is to inform you that the Board of Directors of the Company, in their meeting held on Thursday, 19th September, 2019 (Timings: Meeting commenced at 04.00 p.m. and concluded at 04.40 p.m.) have, inter-alia, subject to approval of members of the Company, considered and approved the following: -
-
- Increase in Authorized · Share Capital of the Company from Rs. 210,00,00,000/- (Rupees Two Hundred Ten Crores Only) divided into 45,00,00,000 (Forty-Five Crore) Equity Shares of Rs. 2/- (Rupees Two Only) each and 1,20,00,000 (One Crore Twenty Lakh) Preference Shares of Rs. 100/- (Rupees One Hundred Only) each toRs. 230,00,00,000/- (Rupees Two Hundred Thirty Crore Only) divided into 55,00,00,000 (Fifty-Five Crore) Equity Shares of Rs. 2/- (Rupees Two Only) each and 1,20,00,000 (One Crore Twenty Lakh) Preference Shares of Rs. 100/- (Rupees One Hundred Only) each by creation of additional 10,00,00,000 (Ten Crore) Equity Shares of Rs. 2/- (Rupees Two Only) each.
-
- To issue and_allot in aggregate up-to 3,70,00,000 Warrants for an aggregate amount of up-to Rs. 74,00,00,000/- (Rupees Seventy-Four Crore Only), convertible into 3,70,00,000 Equity Shares of Rs. 2/- (Rupees Two Only) each, at a price not .less than the price determined in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosu~e Requirements) . Regulations 2018 ('ICDR Regulations') to
1/._ 'vsoor<:tro ·
I]) ·
N m Morepen Laboratories Limited "'o ~
Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G. , New' i- 110 001, INDIA · Tel.:+91-11-23324443,23712025, E-mail: corporate mo epen.com,Website:www.morepen.com CIN NO. L24231 HP1984PLC006028 .
. . ~ A
1\0REPEN
promoter group entity(ies) on a preferential basis. The relevant details are given in Annexure A:
Each warrant is convertible into One (1) Equity Share and the conversion can be exercised at any time during the period of 18 months from the date of allotment of warrants, as the case may be, on such other terms and conditions as applicable.
Further, the details as required under SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated 09th September, 2015 with respect to Issuance of Securities is enclosed as Annexure A.
Kindly acknowledge the receipt and take it on your record.
Thanking you,
Yours faithfully,
For Morepen Laboratories Limited
~r -'~10 ~\4)\~ c; . ~• • I') 0\01 0<>\hl (V1pul Ku ava')' ::_ y' 6.(') Company Secretary0'1t * y
Encl.: As Above
Morepen Laboratories Limited
Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G.Marg, New Delhi- 110 001, INDIA Tel. :+91-11 -23324443,237.12025, E-mail: [email protected],Website:www.morepen.com C\N NO. L24231 HP1984PLC006028
Plant & Regd. Off.: MorepenVillage, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205 Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591 , E-mail: [email protected]
Annexure-A
Disclosure pursuant to SEBI (Listing. Obligations & Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015;
| S.no. | Particulars | Information |
|---|---|---|
| 1. | Type of securities proposed to be issued (viz. equity shares, convertibles etc.) |
Fully Convertible Warrants ("Warrants") convertible into Equity Shares of the face value of Rs. 2/- each |
| 2. | Type of issuance (further public offering, rights issue, depository receipts (ADR/GDR), qualified Institutions placement, preferential allotment etc.) |
Preferential allotment |
| 3. | Total number of securities proposed to be issued or the total amount for which the securities will be issued (approximately) |
Warrants convertible into 3,70,00,000 2/- 3,70,00,000 equity shares of Rs. each. (The total amount of investment into the Company would be upto Rs. 74 Cr.) |
| 4. | In case of preferential issue, the listed entity shall disclose the following additional details to the stock exchange(s): |
1. Brook Investments & Financial Services Pvt. Ltd. 35,00,000 warrants 2. Concept Credits & Consultants Pvt. Ltd. - 35,00,000 warrants |
| i) Names of the investors; | 3. Epitome Holdings Private Limited 35,00,000 warrants 4. Scope Credits & ·Financial Services |
|
| Pvt. Ltd.- 35,00,000 warrants 5. Mid-Med Financial Services & Investments Pvt. Ltd. - 35,00,000 warrants |
||
| 6. React Investments Financial & - Services Pvt. Ltd. 35,00,000 |
||
| warrants 7. Solitary Investments Financial & - Services Pvt. Ltd. 35,00,000 warrants |
||
| 8. Square Investments Financial & - Services Pvt. Ltd. 35,00,000 warrants |
||
| 9. Solace Investments Financial & - Services Pvt. Ltd. 35,00,000 |
More pen Laboratories Limited
Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G.M~rg, New ~ g.elhi- 110 001, INDIA Tel. :+91-11-23324443,23712025, E-mail: corporate@;norepen.com, Website:www.morepen.com GIN NO. L24231 HP1984PLC006028
Plant & Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205 Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591, E-mail: [email protected]
ii) Post allotment of securities outcome of the subscription, issue price/ allotted price (in case of convertibles), number of investors; iii) In case of convertibles intimation on conversion of securities or on lapse of the tenure of the instrument; 10.Seed Securities & Services Pvt. Ltd. - 35,00,000 warrants 11.Liquid Holdings Pvt. Ltd.- 20,00,000 warrants Number of Investors: 11 (Eleven) The warrants will be issued at a price of not lower than the price specified under SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. Warrant would be allotted only upon payment of 25% of the price of warrant at the time of allotment. Each warrant is convertible into One (1) equity share and the conversion can be exercised at any time within a period of 18 months from the date of allotment, in one or more tranches, as the case may be and on such other terms and conditions as applicable. Option for conversion of warrants will be available upon payment of full price of warrant before such exercise of option.
warrants
The requisite intimation will be given at the time of conversion of warrants.
Morepen Laboratories Limited
Corp. Off.: 4th Floor,Antriksh Bhawan, 22 K.G.Marg, New Delhi- 110 001, INDIA Tel. :+91-11-23324443,23712025, E-mail: [email protected],Website:www.morepen.com CIN NO. L24231 HP1984;PLC006028
Plant & Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205 Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591, E-mail: [email protected]